The FDA may tighten regulations on at-home genetic tests and will ask an outside panel of experts to weigh in on the pros and cons of gene-based tests that consumers can order from their own home.
Though the FDA believes the biggest risks of direct-to-consumer tests are false positive or false negative results, the watchdog agency said the "DTC model has created public health and social quandaries" because the general public can have tests for serious medical issues delivered to their doorstep without consulting a physician.